Pharming Group NV（PHAR）價格預測

$10.670

+1.128 (+10.57%)收盤時

價格預測

1-Day Price Prediction

+3.51%

1-Week Prediction

+9.32%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

PHAR 相似圖表分析預測

Alphio's PHAR stock price prediction model matches the current Pharming Group NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.04 (+3.51%). The 1-week path is $11.66 (+9.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Pharming Group NV 股票嗎？

Pharming Group NV is not a good buy right now due to its current price of $9.36, which is significantly below the analyst price target range of $37 to $40. Additionally, the stock has a high forward P/E ratio of 212.77, indicating overvaluation concerns. The RSI is at 30.07, suggesting the stock is oversold, but this could indicate further downside risk rather than an immediate buying opportunity.

PHAR 股價於 Thursday 收在 $10.67，此前上漲 +10.57%

Pharming Group NV (PHAR) last closed at $10.67, gaining +10.57%. These facts feed the 1-day and 1-week PHAR price prediction above.

預測驅動因素

Pharming Group NV（PHAR）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 PHAR 最接近的股票，依相似度排序。

CERT

91.59%

-6.04%

AQN

90.77%

-1.40%

TSCO

90.66%

-28.16%

BRZE

90.47%

+4.07%

90.41%

+14.08%

PHAR 季節性分析

Historically the probability of a positive October return for PHAR is 36.51%. January offers the highest probability of a positive month at 59.02%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…